Treating cancer cachexia: an evolving landscape

Currently, there is no licensed treatment and no standard of care for cancer cachexia. Putting this in the context of a condition which impairs the delivery of anti-cancer therapy (through increased side-effects, treatment delays, dose reductions) [1], causes marked distress to patients and their families and is associated with reduced survival, there remains an urgency to progress the research agenda in cancer cachexia [2].

http://ift.tt/2wLDZNa